BELLEVUE ASSET MANAGEMENT, LLC Adaptive Biotechnologies Corporation Transaction History

BELLEVUE ASSET MANAGEMENT, LLC portfolio value:

$77,000
portfolio value

BELLEVUE ASSET MANAGEMENT, LLC quarter portfolio value change:

-11.99%
quarter

Adaptive Biotechnologies Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -8K $7.12 10.74K
Q2 2022 share 0.00% 0 shares -67K $8.09 10.74K
Q1 2022 share 0.00% 0 shares -150K $13.88 10.74K
Q4 2021 share Decrease -1.38% -150 shares -69K $28.33 10.74K
Q3 2021 share Increase +2.93% 310 shares -62K $33.99 10.89K
Q2 2021 share 0.00% 0 shares 3K $40.86 10.58K
Q1 2021 share Increase +1.55% 162 shares -241K $40.26 10.58K
Q4 2020 share 0.00% 0 shares 164K $59.13 10.42K
Q3 2020 share 0.00% 0 shares 3K $48.63 10.42K
Q2 2020 share 0.00% 0 shares 169K $48.38 10.42K
Q1 2020 share Increase +3690.91% 10.15K shares 327K $27.78 10.42K
Q4 2019 share Increase 0.00% 275 shares 8K $29.92 275